Koninklijke Philips Price to Book Ratio 2010-2025 | PHG
Historical price to book ratio values for Koninklijke Philips (PHG) over the last 10 years. The current price to book ratio for Koninklijke Philips as of May 23, 2025 is 1.72.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Koninklijke Philips Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-23 | 22.55 | 1.69 | |
| 2025-03-31 | 24.50 | $13.36 | 1.83 |
| 2024-06-30 | 24.31 | $13.74 | 1.77 |
| 2023-06-30 | 20.23 | $14.41 | 1.40 |
| 2023-03-31 | 16.38 | 0.00 | |
| 2022-06-30 | 19.22 | $17.75 | 1.08 |
| 2021-06-30 | 42.47 | $15.82 | 2.68 |
| 2020-06-30 | 39.27 | $13.57 | 2.89 |
| 2019-06-30 | 34.94 | $14.86 | 2.35 |
| 2018-06-30 | 33.04 | $15.16 | 2.18 |
| 2017-06-30 | 27.29 | $16.14 | 1.69 |
| 2016-12-31 | 22.68 | $16.20 | 1.40 |
| 2016-09-30 | 21.95 | $15.05 | 1.46 |
| 2016-06-30 | 18.50 | $15.04 | 1.23 |
| 2016-03-31 | 20.39 | $13.79 | 1.48 |
| 2015-12-31 | 18.18 | $14.26 | 1.27 |
| 2015-09-30 | 16.76 | $13.95 | 1.20 |
| 2015-06-30 | 18.19 | $13.76 | 1.32 |
| 2015-03-31 | 19.52 | $14.25 | 1.37 |
| 2014-12-31 | 19.98 | $15.94 | 1.25 |
| 2014-09-30 | 21.84 | $15.87 | 1.38 |
| 2014-06-30 | 21.88 | $15.97 | 1.37 |
| 2014-03-31 | 23.30 | $16.54 | 1.41 |
| 2013-12-31 | 24.50 | $15.90 | 1.54 |
| 2013-09-30 | 21.37 | $15.85 | 1.35 |
| 2013-06-30 | 18.02 | $15.44 | 1.17 |
| 2013-03-31 | 18.83 | $16.34 | 1.15 |
| 2012-12-31 | 16.91 | 0.00 | |
| 2012-09-30 | 14.94 | 0.00 | |
| 2012-06-30 | 12.53 | 0.00 | |
| 2012-03-31 | 12.25 | 0.00 | |
| 2011-12-31 | 12.62 | 0.00 | |
| 2011-09-30 | 10.80 | 0.00 | |
| 2011-06-30 | 15.46 | 0.00 | |
| 2011-03-31 | 18.71 | 0.00 | |
| 2010-12-31 | 17.85 | 0.00 | |
| 2010-09-30 | 18.21 | 0.00 | |
| 2010-06-30 | 17.35 | 0.00 | |
| 2010-03-31 | 18.62 | 0.00 | |
| 2009-12-31 | 16.58 | 0.00 | |
| 2009-09-30 | 13.72 | 0.00 | |
| 2009-06-30 | 10.37 | 0.00 | |
| 2009-03-31 | 8.37 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.196B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |